Florida will get a piece of a $19.5 million settlement with Bristol-Myers Squibb Co. in a case alleging the drug company improperly marketed Abilify. According to a multi-state complaint filed by Florida Attorney General Pam Bondi and attorneys general in 42 other states and the District of Columbia, Bristol-Myers Squibb (NYSE: BMY) promoted the antipsychotic drug for treating elderly patients and children for uses that were not approved by the U.S.